Answers are grounded in this paper and cite their sources.
As improved influenza virus vaccines are being developed, the influenza virus neuraminidase (NA) is becoming an important new target for immune responses. By identifying novel epitopes of anti-NA antibodies, we can improve vaccine design. Additionally, characterizing escape mutations in these epitopes aids in identifying NA antigenic drift in circulating viruses.
No takes yet. Share an insight, caveat, or question.
Roubidoux et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: